Cangene gets $144M anthrax contract

The U.S. Department of Health and Human Services exercised an option under a 2005 contract with Cangene (TSX:CNJ) to purchase 10,000 doses of anthrax immune globulin (AIG) for $143.8 million. The contract permits delivery of the product before licensing for potential emergency use. CNJ said it will receive payments upon delivery to the Strategic National Stockpile, which it plans to start next year and complete by the end of 2009. Full payment is contingent upon FDA approval. Under the contract's first phase, CNJ supplied AIG to HHS for preliminary efficacy testing. ...